Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.35 |
| ▸ | FAAH | O00519 | 5/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208988 | 0.94 | TSHR (0.36) | PRKCAFAAHKMT2AALDH1A1GAA | |
| SCHEMBL17035700 | 0.93 | PRKCA (0.34) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL29293697 | 0.92 | PRKCA (0.38) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL20375257 | 0.88 | FKBP1A (0.39) | KMT2AFKBP1AALDH1A1GAA | |
| SCHEMBL16790693 | 0.87 | PRKCA (0.31) | PRKCA | |
| SCHEMBL12457816 | 0.86 | FAAH (0.32) | FAAHMGLL | |
| SCHEMBL9914760 | 0.85 | PTGS1 (0.47) | FAAHMGLLSMN1; SMN2FKBP1AALDH1A1 | |
| SCHEMBL16489106 | 0.85 | PTGS1 (0.39) | FAAHMGLLKMT2ASMN1; SMN2FKBP1A | |
| SCHEMBL10068094 | 0.85 | CHRM2 (0.33) | PRKCABRD4ALDH1A1 | |
| SCHEMBL29293698 | 0.84 | POLB (0.37) | FAAHMGLLKMT2ASMN1; SMN2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006073465-A2 | MODIFIED MICROSURFACES AND METHODS OF THEIR MANUFACTURE | PROTIVERIS, INC. (US) | 2006-07-13 | — | — | WO | claimed |
| US-20050260423-A1 | Modified microsurfaces and methods of their manufacture | PROTIVERIS, INC. | 2005-11-24 | — | — | US | claimed |
| US-8088753-B2 | Heparin conjugates and methods | MEDIPLEX CORPORATION, KOREA (KR) | 2012-01-03 | — | — | US | disclosed |
| EP-2173359-A2 | HEPARIN CONJUGATES AND METHODS | Mediplex Corp. (KR) | 2010-04-14 | — | — | EP | disclosed |
| US-20090149424-A1 | HEPARIN CONJUGATES AND METHODS | MEDIPLEX CORPORATION, KOREA (KR) | 2009-06-11 | — | — | US | disclosed |
| WO-2009005258-A2 | HEPARIN CONJUGATES AND METHODS | MEDIPLEX CORP. (KR) | 2009-01-08 | — | — | WO | disclosed |
| EP-1721603-A1 | Nanoparticles for bioconjugation | Albert-Ludwigs-Universität Freiburg (DE) | 2006-11-15 | — | — | EP | disclosed |
| WO-2006073465-A2 | MODIFIED MICROSURFACES AND METHODS OF THEIR MANUFACTURE | PROTIVERIS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |
| US-20050260423-A1 | Modified microsurfaces and methods of their manufacture | PROTIVERIS, INC. | 2005-11-24 | — | — | US | disclosed |
| EP-1111069-A1 | Modified nucleic acids and their use | BioChip Technologies GmbH (DE) | 2001-06-27 | — | — | EP | disclosed |